ProRhythm Inc.

Impressive clinical results with the first device-based treatment for drug-resistant hypertension – the Symplicity Renal Denervation System from Ardian Inc. (now a subsidiary of Medtronic PLC

Despite widespread and increasing prevalence, atrial fibrillation has frustrated clinicians, device companies, and investors, resulting in only a small number of doctors treating a small number of pat

by Mary Thompson Atrial fibrillation (AF) is a market that has attracted the attention of a large number of established and emerging cardiovascular device companies over the past several years, all ho

Marie Gethins More than 4,000 electrophysiologists (EPs) and cardiologists attended the biannual EuroPACE meeting in Lisbon, Portugal, at the end of June. While there was little to jolt the implantabl